{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:11:46Z","timestamp":1791497506229,"version":"4.3.4"},"reference-count":18,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Vascular Surgery"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1053\/j.semvascsurg.2005.05.002","type":"journal-article","created":{"date-parts":[[2005,9,16]],"date-time":"2005-09-16T13:55:09Z","timestamp":1126878909000},"page":"130-133","source":"Crossref","is-referenced-by-count":7,"title":["Heparin and Other Rapidly Acting Anticoagulants"],"prefix":"10.1053","volume":"18","author":[{"given":"Thomas M.","family":"Hyers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.semvascsurg.2005.05.002_bib1","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1001\/archinte.163.7.759","article-title":"Management of venous thromboembolism\u2014past, present and future","volume":"163","author":"Hyers","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.semvascsurg.2005.05.002_bib2","doi-asserted-by":"crossref","first-page":"188S","DOI":"10.1378\/chest.126.3_suppl.188S","article-title":"Heparin and low-molecular weight heparin. The seventh ACCP conference on antithrombotic and thrombolytic therapy","volume":"128","author":"Hirsh","year":"2004","journal-title":"Chest"},{"key":"10.1053\/j.semvascsurg.2005.05.002_bib3","doi-asserted-by":"crossref","first-page":"311S","DOI":"10.1378\/chest.126.3_suppl.311S","article-title":"Heparin-induced thrombocytopenia: recognition, treatment, and prevention. The seventh ACCP conference on antithrombotic and thrombolytic therapy","volume":"128","author":"Warkentin","year":"2004","journal-title":"Chest"},{"key":"10.1053\/j.semvascsurg.2005.05.002_bib4","doi-asserted-by":"crossref","first-page":"401S","DOI":"10.1378\/chest.126.3_suppl.401S","article-title":"Antithrombotic therapy for venous thromboembolic disease. The seventh ACCP conference on antithrombotic and thrombolytic therapy","volume":"126","author":"B\u00fcller","year":"2004","journal-title":"Chest"},{"key":"10.1053\/j.semvascsurg.2005.05.002_bib5","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJMoa011099","article-title":"Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery","volume":"345","author":"Bauer","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semvascsurg.2005.05.002_bib6","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/S0140-6736(02)08648-8","article-title":"Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery","volume":"359","author":"Turpie","year":"2002","journal-title":"Lancet"},{"key":"10.1053\/j.semvascsurg.2005.05.002_bib7","doi-asserted-by":"crossref","first-page":"867","DOI":"10.7326\/0003-4819-140-11-200406010-00007","article-title":"Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis","volume":"140","author":"B\u00fcller","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.semvascsurg.2005.05.002_bib8","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa035451","article-title":"Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism","volume":"349","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semvascsurg.2005.05.002_bib9","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1001\/archinte.163.11.1337","article-title":"Duration of prophylaxis against venous thromboembolism with fondaparinux after hip fracture surgery","volume":"163","author":"Eriksson","year":"2003","journal-title":"Arch Intern Med"},{"issue":"7, pt 2","key":"10.1053\/j.semvascsurg.2005.05.002_bib10","doi-asserted-by":"crossref","first-page":"88S","DOI":"10.1592\/phco.24.10.88S.36122","article-title":"Special considerations with fondaparinux therapy","volume":"24","author":"Dager","year":"2004","journal-title":"Pharmacotherapy"},{"key":"10.1053\/j.semvascsurg.2005.05.002_bib11","doi-asserted-by":"crossref","first-page":"265S","DOI":"10.1378\/chest.126.3_suppl.265S","article-title":"New anticoagulant drugs. The seventh ACCP conference on antithrombotic and thrombolytic therapy","volume":"128","author":"Weitz","year":"2004","journal-title":"Chest"},{"key":"10.1053\/j.semvascsurg.2005.05.002_bib12","doi-asserted-by":"crossref","first-page":"338S","DOI":"10.1378\/chest.126.3_suppl.338S","article-title":"Prevention of venous thromboembolism. The seventh ACCP conference on antithrombotic and thrombolytic therapy","volume":"128","author":"Geerts","year":"2004","journal-title":"Chest"},{"key":"10.1053\/j.semvascsurg.2005.05.002_bib13","doi-asserted-by":"crossref","first-page":"858","DOI":"10.7326\/0003-4819-135-10-200111200-00006","article-title":"Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty","volume":"135","author":"Hull","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.semvascsurg.2005.05.002_bib14","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1001\/archinte.162.17.1966","article-title":"Prolonged thromboprophylaxis with oral anticoagulants after total hip arthroplasty","volume":"162","author":"Prandoni","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.semvascsurg.2005.05.002_bib15","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1056\/NEJMoa035162","article-title":"Comparison of ximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacement","volume":"349","author":"Francis","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semvascsurg.2005.05.002_bib16","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1001\/jama.293.6.681","article-title":"Ximelagatran vs low-molecular-weight heparin and warfarin for the treatment of deep vein thrombosis","volume":"293","author":"Fiessinger","year":"2005","journal-title":"JAMA"},{"key":"10.1053\/j.semvascsurg.2005.05.002_bib17","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1001\/jama.293.6.690","article-title":"Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation","volume":"293","year":"2005","journal-title":"JAMA"},{"key":"10.1053\/j.semvascsurg.2005.05.002_bib18","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1001\/jama.293.6.736","article-title":"Ximelagatran\u2014promises and concerns","volume":"293","author":"Gurewich","year":"2005","journal-title":"JAMA"}],"container-title":["Seminars in Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0895796705000220?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0895796705000220?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T08:25:08Z","timestamp":1548145508000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0895796705000220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["S0895796705000220"],"URL":"https:\/\/doi.org\/10.1053\/j.semvascsurg.2005.05.002","relation":{},"ISSN":["0895-7967"],"issn-type":[{"value":"0895-7967","type":"print"}],"subject":[],"published":{"date-parts":[[2005,9]]}}}